STOK
Stoke Therapeutics Inc
24.30$
-0.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 7.9 | 12.7 | 34.0 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 263.4 | 83.2 | 55.2 | 29.2 | 24.3 | 53.0 | 18.7 | 27.1 | 79.6 | 49.7 | 41.4 | 17.2 | 2.1 | 3.3 | 6.7 | 10.0 | 64.1 | 78.3 | |
| – | – | – | – | – | 3.8 | 3.0 | 3.2 | 3.5 | 3.9 | 5.8 | 7.6 | 5.2 | 4.8 | 3.9 | 4.1 | 3.3 | 2.3 | 2.5 | 2.0 | 1.7 | 2.5 | 1.0 | 1.5 | 4.4 | 3.1 | 3.0 | 2.7 | 1.1 | 2.0 | 4.5 | 5.3 | 5.2 | 6.2 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 235.9 | 72.6 | 43.1 | 20.3 | 11.3 | 31.5 | -1.6 | 5.6 | 57.1 | 37.1 | 32.6 | 13.7 | 0.7 | 2.8 | 6.3 | 9.6 | 59.3 | 74.3 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.3 | 10.2 | 30.2 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.8 | 10.9 | 26.3 | 41.2 | – | – | |
| – | – | – | – | – | -2.2% | -3.6% | -4.6% | -5.0% | -5.1% | -3.9% | -2.0% | -3.7% | -4.8% | -6.7% | -7.7% | -2.0% | -3.9% | -5.8% | -9.9% | -25.2% | -19.4% | -49.0% | -34.7% | -13.7% | -10.7% | -12.2% | -13.9% | 17.4% | 9.2% | 3.8% | 2.4% | -7.2% | -8.4% | |
| Margins | ||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 21.8% | 57.4% | 67.1% | 71.5% | 72.1% | 50.4% | 49.5% | 46.1% | 40.2% | 69.4% | 79.5% | 93.9% | 99.4% | 100.0% | 99.5% | 98.9% | 90.4% | 84.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -3,134.4% | -1,560.6% | -1,113.3% | -841.2% | -716.2% | -1,269.4% | -1,215.0% | -1,307.0% | -1,509.9% | -755.7% | -700.6% | -277.3% | 20.0% | 20.2% | 13.2% | -11.2% | -577.5% | -809.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -3,122.0% | -1,546.2% | -1,093.0% | -814.7% | -679.8% | -1,186.7% | -1,118.0% | -1,192.3% | -1,383.4% | -683.3% | -629.9% | -243.4% | 26.3% | 26.3% | 19.7% | -3.7% | -529.2% | -753.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -537.2% | -327.0% | -323.0% | -288.8% | -611.4% | -1,029.1% | -914.7% | -941.6% | -1,092.9% | -531.9% | -505.9% | -238.1% | 36.2% | 30.6% | 25.5% | 24.4% | -460.4% | -654.9% | |
| Returns | ||||||||||||||||||||||||||||||||||
| – | – | – | -11.9% | -16.4% | -8.8% | -11.3% | -14.4% | -17.6% | -21.0% | -24.8% | -18.3% | -21.3% | -26.3% | -32.0% | -39.4% | -39.0% | -43.0% | -48.9% | -54.7% | -46.3% | -55.2% | -59.8% | -65.6% | -77.3% | -42.7% | -45.4% | -38.9% | 14.4% | 15.7% | 13.2% | -2.0% | -43.0% | -60.2% | |
| – | – | – | -11.6% | -15.9% | -8.6% | -11.1% | -14.1% | -17.0% | -20.3% | -23.9% | -17.5% | -20.8% | -25.3% | -29.9% | -35.9% | -29.6% | -32.0% | -36.0% | -39.5% | -35.1% | -40.9% | -43.1% | -45.9% | -52.9% | -33.7% | -36.0% | -32.8% | 12.4% | 13.6% | 11.3% | -1.6% | -38.3% | -52.8% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||
| 1.8 | – | – | – | -99 | – | – | – | -210 | -201 | -190 | -286 | – | -168 | -148 | -143 | -83 | -66 | -111 | -111 | -188 | -190 | -187 | -189 | -176 | -191 | -148 | -126 | -272 | -99 | -80 | -81 | -153 | -108 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -5.1 | -1.8 | -1.9 | – | – | – | |
| – | – | – | 97.7% | 96.7% | 98.0% | 97.8% | 98.1% | 97.1% | 96.8% | 96.3% | 96.0% | 97.7% | 96.5% | 93.6% | 91.2% | 76.0% | 74.4% | 73.5% | 72.2% | 75.9% | 74.0% | 72.1% | 69.9% | 68.4% | 78.9% | 79.1% | 84.3% | 86.0% | 87.1% | 85.5% | 84.2% | 89.1% | 87.7% | |
| – | – | – | – | 0.0 | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||
| – | – | – | -0.53 | -0.54 | -0.67 | -0.81 | -1.28 | -1.14 | -1.29 | -1.44 | -1.49 | -1.58 | -1.83 | -2.07 | -2.33 | -2.50 | -2.45 | -2.53 | -2.56 | -2.33 | -2.38 | -2.34 | -2.33 | -2.35 | -1.86 | -1.87 | -1.56 | 0.85 | 0.90 | 0.69 | -0.12 | -2.69 | -3.15 | |
| – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 0.16 | 0.23 | 0.31 | 0.34 | 0.20 | 0.21 | 0.20 | 0.17 | 0.27 | 0.30 | 0.64 | 3.21 | 3.43 | 3.51 | 3.16 | 0.51 | 0.42 | |
| -0.05 | – | – | 4.47 | 3.29 | 7.67 | 7.14 | 8.86 | 6.52 | 6.15 | 5.79 | 8.16 | 7.44 | 6.95 | 6.46 | 5.91 | 6.41 | 5.71 | 5.18 | 4.69 | 5.03 | 4.30 | 3.91 | 3.55 | 3.03 | 4.35 | 4.12 | 4.02 | 5.89 | 5.74 | 5.26 | 6.04 | 6.26 | 5.23 | |
| – | – | – | -0.51 | -0.55 | -0.65 | -0.78 | -1.29 | -1.14 | -1.23 | -1.29 | -1.23 | -1.43 | -1.60 | -1.70 | -1.85 | -0.43 | -0.52 | -0.75 | -0.91 | -2.09 | -2.06 | -1.91 | -1.84 | -1.85 | -1.45 | -1.50 | -1.53 | 1.16 | 1.05 | 0.89 | 0.77 | -2.34 | -2.74 | |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.